After the FDA declared GLP-1 shortages resolved in early 2025 and began cracking down on compounding pharmacies, Ro and Hims & Hers shifted to partnering with Eli Lilly and Novo Nordisk's direct-to-consumer cash-pay pharmacies, LillyDirect (launched January 2024) and NovoCare (launched March 2025), that the manufacturers had built to bypass insurance and PBM channels and capture the unprecedented consumer demand around by GLP-1s, for which ~60% of patients are denied coverage by their insurers
Insufficient protein intake accelerates muscle loss during weight loss
Medication Access Prefer providers that publicly name their 503A pharmacy partners and disclose the additive in each compounded formulation
If you are using the 2mL ratio, draw 2mL of air
Januvia (sitagliptin) , by contrast, is a DPP-4 inhibitor that works by preventing the breakdown of endogenous incretin hormones, including GLP-1 and glucose-dependent insulinotropic polypeptide (GIP)
Obesity is no different. When Drucker started in endocrinology in the 1980s, he didnt have many tools to help patients
